Hoth Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
325
across all filing types
Latest filing
2026-05-27
Regulatory Filings
Country
US
United States of America
Listing
US
HOTH
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company that acts as a catalyst in early-stage pharmaceutical research and development. The company focuses on advancing promising drug candidates from discovery through pre-clinical and clinical testing to address unmet medical needs. Its development pipeline includes innovative therapeutics for conditions such as skin disorders. Guided by a patient-centric mission to improve quality of life, Hoth Therapeutics also utilizes artificial intelligence to support its drug development programs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| PROSPECTUS SUPPLEMENT | 2026-05-27 | English | |
| CURRENT REPORT | 2026-05-27 | English | |
| CURRENT REPORT | 2026-05-21 | English | |
| QUARTERLY REPORT | 2026-05-15 | English | |
| 8-K - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-05-06 | English | |
| 8-K - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-05-04 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 47846174 | PROSPECTUS SUPPLEMENT | 2026-05-27 | English | ||
| 47540654 | CURRENT REPORT | 2026-05-27 | English | ||
| 46753358 | CURRENT REPORT | 2026-05-21 | English | ||
| 46362293 | QUARTERLY REPORT | 2026-05-15 | English | ||
| 41998159 | 8-K - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-05-06 | English | ||
| 41071328 | 8-K - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-05-04 | English | ||
| 34650412 | 8-K - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-04-16 | English | ||
| 34650389 | 424B5 - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-04-16 | English | ||
| 33192520 | 8-K - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-04-02 | English | ||
| 33180659 | 424B5 - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-04-02 | English | ||
| 33066014 | 10-K - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-03-27 | English | ||
| 13051071 | CURRENT REPORT | 2026-01-16 | English | ||
|
2025
3 filings
| |||||
| 13051074 | Regulatory Filings 2025 | 2025-12-05 | English | ||
| 13051075 | REGISTRATION STATEMENT | 2025-11-14 | English | ||
| 13051076 | PROSPECTUS SUPPLEMENT | 2025-11-13 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Alpha Tau Medical Ltd.
Clinical-stage oncology firm developing alpha radiation the…
|
DRTS | US | Professional, scientific and te… |
|
Alteogen Inc.
Biopharmaceutical firm developing biologics with proprietar…
|
196170 | KR | Professional, scientific and te… |
|
ALTERITY THERAPEUTICS LIMITED
Clinical-stage developer of disease-modifying therapies for…
|
ATH | AU | Professional, scientific and te… |
|
AlzeCure Pharma
Develops therapies for severe diseases, focusing on Alzheim…
|
ALZCUR | SE | Professional, scientific and te… |
|
AMPLIA THERAPEUTICS LIMITED
Clinical-stage developer of FAK inhibitors for solid tumors…
|
ATX | AU | Professional, scientific and te… |
|
ANAPTYSBIO, INC
Clinical-stage biotech developing immunology therapeutics f…
|
ANAB | US | Professional, scientific and te… |
|
ANATARA LIFESCIENCES LTD
Develops non-antibiotic gastrointestinal health solutions f…
|
ANR | AU | Professional, scientific and te… |
|
AngioLab, Inc.
Develops angiogenesis inhibitors for pharmaceuticals and he…
|
251280 | KR | Professional, scientific and te… |
|
Anhui Wanbang Pharmaceutical Technology Co.,Ltd.
Pharmaceutical CRO specializing in clinical trials, BE stud…
|
301520 | CN | Professional, scientific and te… |
|
Anixa Biosciences Inc
A clinical-stage biotech developing therapies and vaccines …
|
ANIX | US | Professional, scientific and te… |
Hoth Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34935/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34935 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34935 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34935 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34935}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Hoth Therapeutics, Inc. (id: 34935)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.